91ºÚÁÏÍø

Agreement to accelerate development of potential treatments for rare, endocrine, metabolic, and neurological conditions associated with primary and secondary ubiquinone deficiencies which belong to the wider class of mitochondrial diseases | An estimated 1 in 5,000 adults worldwide has a mitochondrial disease | Clarus to pay 91ºÚÁÏÍø $350,000 upfront and up to $10.5 million in potential development and regulatory milestones

Classified as: Coenzyme Q10, mitochondria, Technologies for License
Published on: 16 Sep 2021

The popular dietary supplement ubiquinone, also known as Coenzyme Q10, is widely believed to function as an antioxidant, protecting cells against damage from free radicals. But a new study by scientists at 91ºÚÁÏÍø finds that ubiquinone is not a crucial antioxidant -- and that consuming it is unlikely to provide any benefit.

Classified as: Biology, Research, mitochondria, food, aging, nutrition, 91ºÚÁÏÍø News, antioxidant, Coenzyme Q10, dietary supplement, Hekimi, Nature Communications, ubiquinone, free radicals
Published on: 6 Mar 2015
Back to top